How antibody levels can predict which children will outgrow their peanut allergy
Australian researchers have discovered how changes in antibody levels over time can predict which children are likely to outgrow their peanut allergy.
Medical Xpress
Research finds genetic variation that could lead to increased risk of viral infections
A new study, led by Jesmond Dalli, professor of molecular pharmacology at Queen Mary University of London, has found that people with a genetic mutation that leads to a reduction in a protein called LGR6, found on the surface of immune cells, have a de…
How ultrasound and microbubbles could deliver immunotherapy to the brain
Malignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. Treatments are limited by the blood–brain barrier, a unique structure within the brain formed by tightly connected cells…
Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccine
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and d…
Scientists discover how deadly skin cancer evades the human immune system
An international study led by Dr. Li Qi-Jing from the Agency for Science, Technology and Research (A*STAR) has revealed a mechanism by which melanoma, the most aggressive form of skin cancer, evades the immune system.
Scientists pinpoint new vaccine adjuvant that promotes potent anti-tumor immunity
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant called C100 promotes potent anti-tumor immunity when it is injec…
Supercharging immune cells to battle blood cancer: Advances in cancer immunotherapy
Cancer has a profound impact on human life, and immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment. However, ICT faces challenges such as low overall response rates and the emergence of immune-related adverse events. To ove…
New treatment could reverse hair loss caused by autoimmune skin disease alopecia areata
Researchers at MIT, Brigham and Women’s Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including children.
Study reveals role of iron in allergic asthma and points to potential new therapies
New USC research shows that iron serves as a gas pedal driving certain immune cells that cause inflammation in the lungs during an allergic asthma attack—and blocking or limiting iron may reduce the severity of symptoms.
Strengthening CAR-T therapy to work against solid tumors
Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance that could transform cance…